Glenn Prestwich
Fondateur chez SentrX Animal Care, Inc.
Profil
Glenn D.
Prestwich was the founder of Carbylan Therapeutics, Inc. (founded in 2005) where he served as the Chief Scientific Officer from 2005 to 2010.
He is also the founder of Clear Solutions Biotech, Inc. (founded in 1994) and SentrX Animal Care, Inc. (founded in 2006) where he currently holds the title of Senior Scientific Advisor.
Dr. Prestwich's current job(s) include being the Principal at GlycoMira LLC and a Professor at the University of Utah since 1996.
His former job(s) include being a Director at Brickell Subsidiary, Inc., Chief Scientific Officer at Glycosan BioSystems, Inc., and Chief Scientific Officer at Echelon Biosciences, Inc. (from 1997 to 2003).
Dr. Prestwich obtained a doctorate degree from Stanford University in 1974 and an undergraduate degree from the California Institute of Technology in 1970.
Postes actifs de Glenn Prestwich
| Sociétés | Poste | Début |
|---|---|---|
| University of Utah | Corporate Officer/Principal | 01/01/1996 |
SentrX Animal Care, Inc.
 SentrX Animal Care, Inc. Pharmaceuticals: MajorHealth Technology SentrX Animal Care, Inc. provides veterinary care services for animals. Its products include gels, film and field treatment kits, film-on-gauzes, adhesion prevention films, spray bottles, and corneal repair gel drops. The company’s products are used for horses, cats and dogs. The company was founded by Richard K. Koehn and Glenn D. Prestwich in 2006 and is headquartered in Salt Lake City, UT. | Fondateur | 15/02/2010 |
| GlycoMira LLC | Corporate Officer/Principal | - |
Anciens postes connus de Glenn Prestwich
| Sociétés | Poste | Fin |
|---|---|---|
Echelon Biosciences, Inc.
 Echelon Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Echelon Biosciences, Inc. engages in the development of novel assays and reagents for lipid research. Its products include chemical reagents, biological reagents, and assays. The company was founded on October 3, 1997 and is headquartered in Salt Lake City, UT. | Directeur Technique/Scientifique/R&D | - |
| Clear Solutions Biotech, Inc. | Fondateur | 01/01/2001 |
Brickell Subsidiary, Inc.
 Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Brickell Subsidiary, Inc. operates as a clinical-stage pharmaceutical company. It focuses on the development of differentiated, innovative drug therapies for the treatment of skin diseases. The firm specializes in Hyperhidrosis, Cutaneous T-Cell Lymphoma and Psoriasis areas. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in November 2009 and is headquartered in Boulder, CO. | Directeur/Membre du Conseil | - |
Glycosan BioSystems, Inc.
 Glycosan BioSystems, Inc. Pharmaceuticals: MajorHealth Technology Glycosan BioSystems, Inc. develops, manufactures, and markets formulations of a hyaluronan-based synthetic extra cellular matrix. Its products are used cell culture, stem cell culture, tissue engineering, and cell therapy. The company was founded by Glenn Prestwich, William Tew, and Anna Scott in January 2006 and is located in Salt Lake City, UT. | Directeur Technique/Scientifique/R&D | - |
Carbylan Therapeutics, Inc.
 Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carbylan Therapeutics, Inc. engages in the development and market of medical devices and drug combination products to treat the pain associated with osteoarthritis. It offers Hydros Joint Therapy and Hydros-TA Joint Therapy, viscoelastic hyaluronan-based products designed to provide long term relief of the pain associated with osteoarthritis using a single intra-articular injection. The company was founded by Richard R. Orlandi, Albert Park, Glenn D. Prestwich and Richard K. Koehn in March 2004 and is headquartered in Palo Alto, CA. | Fondateur | - |
Formation de Glenn Prestwich
| Stanford University | Doctorate Degree |
| California Institute of Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Carbylan Therapeutics, Inc.
Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carbylan Therapeutics, Inc. engages in the development and market of medical devices and drug combination products to treat the pain associated with osteoarthritis. It offers Hydros Joint Therapy and Hydros-TA Joint Therapy, viscoelastic hyaluronan-based products designed to provide long term relief of the pain associated with osteoarthritis using a single intra-articular injection. The company was founded by Richard R. Orlandi, Albert Park, Glenn D. Prestwich and Richard K. Koehn in March 2004 and is headquartered in Palo Alto, CA. | Health Technology |
Glycosan BioSystems, Inc.
Glycosan BioSystems, Inc. Pharmaceuticals: MajorHealth Technology Glycosan BioSystems, Inc. develops, manufactures, and markets formulations of a hyaluronan-based synthetic extra cellular matrix. Its products are used cell culture, stem cell culture, tissue engineering, and cell therapy. The company was founded by Glenn Prestwich, William Tew, and Anna Scott in January 2006 and is located in Salt Lake City, UT. | Health Technology |
SentrX Animal Care, Inc.
SentrX Animal Care, Inc. Pharmaceuticals: MajorHealth Technology SentrX Animal Care, Inc. provides veterinary care services for animals. Its products include gels, film and field treatment kits, film-on-gauzes, adhesion prevention films, spray bottles, and corneal repair gel drops. The company’s products are used for horses, cats and dogs. The company was founded by Richard K. Koehn and Glenn D. Prestwich in 2006 and is headquartered in Salt Lake City, UT. | Health Technology |
| GlycoMira LLC | |
Brickell Subsidiary, Inc.
Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Brickell Subsidiary, Inc. operates as a clinical-stage pharmaceutical company. It focuses on the development of differentiated, innovative drug therapies for the treatment of skin diseases. The firm specializes in Hyperhidrosis, Cutaneous T-Cell Lymphoma and Psoriasis areas. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in November 2009 and is headquartered in Boulder, CO. | Health Technology |
Echelon Biosciences, Inc.
Echelon Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Echelon Biosciences, Inc. engages in the development of novel assays and reagents for lipid research. Its products include chemical reagents, biological reagents, and assays. The company was founded on October 3, 1997 and is headquartered in Salt Lake City, UT. | Health Technology |
| Clear Solutions Biotech, Inc. |
